Difference between revisions of "Brook Jackson"
(desc and expand) |
m (→Other Transaction Authority: typo) |
||
| Line 12: | Line 12: | ||
=== Other Transaction Authority === | === Other Transaction Authority === | ||
| − | Brook Jackson's case is cited by researchers including [[Sasha | + | Brook Jackson's case is cited by researchers including [[Sasha Latypova]] as having highlighted the [[Pentagon|USDoD]]'s use of the [[Other Transaction Authority]] to order the jabs as prototype countermeasures, avoiding contract and pharmaceutical laws that would have applied to them if they had been classed as medical treatments. |
=== Case dismissed === | === Case dismissed === | ||
In his March 31 ruling, U.S. District judge [[Michael Truncale]] dismissed the case.<ref>https://youtu.be/z_bNs0pk5bA</ref> | In his March 31 ruling, U.S. District judge [[Michael Truncale]] dismissed the case.<ref>https://youtu.be/z_bNs0pk5bA</ref> | ||
{{SMWDocs}} | {{SMWDocs}} | ||
Revision as of 11:29, 24 April 2023
 Brook Jackson    (whistleblower) | |
|---|---|
| Exposed | COVID-19/Vaccines |
A whistleblower who witnessed numerous violations of standard operating procedure in the experiments carried out regards COVID jabs | |
Brook Jackson is a whistleblower who witnessed numerous violations of standard operating procedure in what she thought were trials of the COVID jabs' "safety and efficacy". She reports that she "repeatedly informed her superiors of poor laboratory management, patient safety concerns and data integrity issues" during the two weeks she was employed by Ventavia in September 2020.[1]
She gave a cache of information to the BMJ, which published a piece on her claims.[2]
Court case
In January 2021 Jackson sued Pfizer, Ventavia and ICON PLC, another Pfizer contractor. She charged that the companies committed numerous violations of the False Claims Act (FCA) during the clinical trials.
Other Transaction Authority
Brook Jackson's case is cited by researchers including Sasha Latypova as having highlighted the USDoD's use of the Other Transaction Authority to order the jabs as prototype countermeasures, avoiding contract and pharmaceutical laws that would have applied to them if they had been classed as medical treatments.
Case dismissed
In his March 31 ruling, U.S. District judge Michael Truncale dismissed the case.[3]
Related Document
| Title | Type | Publication date | Author(s) | Description |
|---|---|---|---|---|
| Document:Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial | article | 2 November 2021 | Paul D Thacker | Whistleblowers from a contract research company helping to carry out Pfizer’s pivotal covid-19 vaccine trial say never experienced such a “helter skelter" work environment, saying speed may have come at the cost of data integrity and patient safety. |
